News Overview

Agarwal Industrial Corporation Limited has informed the Exchange about Investor Presentation F Y 2022

Hester Biosciences Limited has informed the Exchange about press release dated 20-May-2022 titled 20220520 Press Release

Dr. Reddys Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 13-Jul-2022 to 15-Jul-2022 for the purpose of Dividend.

Wheels India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that the Board of Directors of the Company in its Meeting held today i.e. 20th May, 2022 have approved the appointment of Mr. Bharat Singh (DIN: 08222884) as an Alternate Director (Non-Executive, Nominee Director) for Mr. G.V. Ravishankar, Non-Executive, Nominee Director of the Company with immediate effect. In compliance with Circular No. NSE/CML/2018/02 issued by National Stock Exchange of India Limited and Circular No. LIST/COMP/14/2018-19 issued by BSE Limited (both circulars dated June 20, 2018), this is to confirm that Mr. Bharat Singh has not been debarred from holding the office of Director by virtue of any SEBI Order or any other authority. The requisite details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III thereof and SEBI Circular No. CIR/CFD/CMD/4/2015 dated

Orient Green Power Company Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.

Camlin Fine Sciences Limited has informed the Exchange about Investor Presentation

ICICI Lombard General Insurance Company Limited has informed the Exchange about resignation of Vishakha Mulye as Non Executive - Non Independent Director of the company w.e.f. 20-May-2022

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 09-May-2022 titled Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005% 0.064%

Indraprastha Medical Corporation Limited has informed the Exchange that Board of Directors at its meeting held on 20-May-2022, declared Dividend of Rs. 2.50 per equity share.